09606.HK
Duality Biotherapeutics, Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 180.70
−1.53%Latest reported
- Last report date
- Aug 28, 2026
- EPS actual
- -HKD 12
- EPS estimate
- —
- Revenue actual
- HKD 253.0M
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 28, 2026